Articles

Showing 43 articles

• Original Research

  Published 12 October 2026

  Advanced stage at diagnosis and aggressive histology dominate prostate cancer presentation in Kenya: a registry analysis

  Charles Waihenya · Daniel Kinyuru Ojuka · Camille Ragin · Charnita Zeigler-Johnson · Regina Wachuka Mbugua · S. M. Thumbi

  Frontiers in Cancer Control and Society

  doi 10.3389/fcacs.2026.1946844

• Perspective

  Published 12 October 2026

  Resistance in the edges: a relational framework for treatment resistance in genitourinary cancers

  Daniele Silva Lacerda · Rosiane Batista Mastelari · Tiago Veiras Collares

  Frontiers in Oncology

  doi 10.3389/fonc.2026.1974982

• Review

  Published 9 October 2026

  Paradigm shifts in prostate biopsy strategies in the era of precision medicine

  Chenhui Tang · Zhen Liang · Weigang Yan

  Frontiers in Surgery

  doi 10.3389/fsurg.2026.1928043

• Original Research

  Published 9 October 2026

  Study on the promoting effect of microplastic exposure on prostate cancer migration and invasion based on network toxicology and single-cell sequencing technology

  Haiyang Jiang · Ying Bi · Longguo Dai · Yong Zhu · Ruikang Zhang · Chen Hu · Hong Yang · Jun Li · Chongjian Zhang · Yu Bai · Ruiqian Li

  Frontiers in Oncology

  doi 10.3389/fonc.2026.1973812

• Case Report

  Published 9 October 2026

  Durable biochemical and radiographic response during toripalimab treatment in MSI-high/TMB-high mCRPC: a case report

  Junhang Ding · Zhengxin Liu · Jinyu Tian · Feng Wang · Chuan Liu

  Frontiers in Oncology

  doi 10.3389/fonc.2026.1907524

• Review

  Published 9 October 2026

  Prostate cancer: advancements in targeted therapies

  Ilesha Ewart · Manreet Randhawa

  Frontiers in Endocrinology

  doi 10.3389/fendo.2026.1924299

• Original Research

  Published 8 October 2026

  Longitudinal CT-derived muscle–fat–bone remodeling following androgen deprivation therapy initiation in prostate cancer

  Manuela Montatore · Gianmichele Muscatella · Federica Masino · Eluisa Muscogiuri · Giuseppe Guglielmi

  Frontiers in Urology

  doi 10.3389/fruro.2026.1985221

• Original Research

  Published 7 October 2026

  Automated voxel-based prostate volumetry improves PSA density–based detection of clinically significant prostate cancer in the PSA gray zone: comparison with manual segmentation and the ellipsoid formula

  Jing Han · Yi Qiu · Houdong Liu · Jing Wen

  Frontiers in Digital Health

  doi 10.3389/fdgth.2026.1897681

• Original Research

  Published 6 October 2026

  Integrating Mendelian randomization with single-cell and spatial transcriptomics to investigate gut microbiota-associated genetic signals and molecular characteristics in prostate cancer

  Chenjie Qiu · Huilin Zhang · Zongmin Du · Yuan Gao · Liangliang Dai

  Frontiers in Cellular and Infection Microbiology

  doi 10.3389/fcimb.2026.1899354

• Original Research

  Published 6 October 2026

  Prognostic value of postoperative dynamic PNI trajectories for biochemical recurrence in patients with high-risk localized prostate cancer: a longitudinal trajectory clustering study

  Bo Yu · Xuchao Dai · Jianguo Zhu

  Frontiers in Nutrition

  doi 10.3389/fnut.2026.1963784

• Mini Review

  Published 1 October 2026

  From inherited susceptibility to tumor state: toward a stage-aware architecture for genomic risk stratification in prostate cancer

  Ziheng Zheng · Xuechun Yang · Minqian Ou · Yuedong Chen · Deyong Gan

  Frontiers in Genetics

  doi 10.3389/fgene.2026.1969511

• Case Report

  Published 16 September 2026

  Case Report: cytoreductive prostatectomy after platinum–etoposide chemotherapy for de novo metastatic prostatic small cell neuroendocrine carcinoma

  Yanxin Wang · Qiwu Wang · Hang Yang

  Frontiers in Urology

  doi 10.3389/fruro.2026.1934905

• Original Research

  Published 15 September 2026

  Predicting disease progression under a “treatment-naive” counterfactual scenario in a competing risks framework

  Daniela Zugna · Nicolas Destefanis · Renata Zelic · Andreas Pettersson · Lorenzo Richiardi

  Frontiers in Epidemiology

  doi 10.3389/fepid.2026.1850482

• Original Research

  Published 7 September 2026

  Bridging to systemic therapy: PSMA-PET-based early and repetitive stereotactic body radiotherapy for nodal and bone oligo-recurrent prostate cancer

  Arne Grün · Alexandra Partyka · Markus Galler · Torsten Schlomm · Dirk Böhmer · Kurt Miller · Daniel Zips · Goda Kalinauskaite

  Frontiers in Urology

  doi 10.3389/fruro.2026.1738508

• Original Research

  Published 28 August 2026

  Association of selected ELAC2, MSR1, RNASEL and KLK3 polymorphisms with prostate cancer susceptibility in a Hungarian cohort

  Sebestyen Kovacs · Renata Szalai · Laszlo Barati · Kinga Hadzsiev

  Pathology and Oncology Research

  doi 10.3389/pore.2026.1612550

• Systematic Review

  Published 17 August 2026

  Use of androgen suppression therapy at salvage radiotherapy in recurrent prostate cancer: a systematic review with meta-analysis

  Maria Juliana Chaves Medina · Rodolfo Varela Ramírez · Wilfredo Donoso Donoso · Jaime Moreno-Chaparro · Javier Eslava-Schmalbach

  Frontiers in Urology

  doi 10.3389/fruro.2026.1836469

• Original Research

  Published 7 August 2026

  Glucagon-like peptide-1 receptor agonist versus other anti-diabetic agents on patients with prostate cancer undergoing androgen-deprivation therapy

  Sheng-Chi Huang · Wan-Yu Cheng · Cheng-You Hou · Jheng-Yan Wu · Chih-Cheng Lai · Wen-Hsin Tseng

  Frontiers in Urology

  doi 10.3389/fruro.2026.1855180

• Review

  Published 31 July 2026

  Circulating tumour DNA in mCRPC: bridging tumour biology and real-time treatment monitoring

  Chimbabantu Kaoma · Mike Sathekge · Joseph Chalwe · Kgomotso Mokoala · Mankgopo Kgatle

  Frontiers in Molecular Medicine

  doi 10.3389/fmmed.2026.1852641

• Original Research

  Published 29 July 2026

  MRI-derived T stage predicts nodal positivity on PSMA PET/CT in high-risk primary prostate cancer

  Michael Courtney · Robert Whiriskey · Ciaran Johnston · Niall Sheehy

  Frontiers in Nuclear Medicine

  doi 10.3389/fnume.2026.1854064

• Review

  Published 15 July 2026

  PSMA-targeted radioligand therapy in advanced prostate cancer: a narrative review of ^177Lu-PSMA, emerging ^225Ac-PSMA strategies, and therapeutic sequencing

  Natalia Gierulska · Nina Jankowska · Adrianna Kwiatkowska · Piotr Kuchno · Kinga Łysak · Katarzyna Szklener · Kamil Kośmider · Magdalena Skórzewska

  Oncology Reviews

  doi 10.3389/or.2026.1834484

• Original Research

  Published 3 July 2026

  Socio-demographic characteristics, point prevalence and referral patterns of prostate cancer patients in a South African rural teaching hospital: a cross-sectional study

  Xolelwa Ntlongweni · Siyabonga Sibulawa · Sibusiso Cyprian Nomatshila · Wezile Wilson Chitha · Anathi Limaphi · Tronic Sithole · Sikhumbuzo Advisor Mabunda

  Frontiers in Cancer Control and Society

  doi 10.3389/fcacs.2026.1858841

• Original Research

  Published 2 July 2026

  N-Gene and T-Gene deregulation networks: a data-driven causal framework for the analysis of gene interventions in cancer

  Frank Castel · Roberto Herrero · Jean Pierre Gómez · Gabriel Gil · Augusto Gonzalez

  Frontiers in Systems Biology

  doi 10.3389/fsysb.2026.1861211

• Systematic Review

  Published 19 June 2026

  Cancer-related mortality among solid organ transplant recipients: systematic review and meta-analysis

  Charlotte Stephens · Rafeea Shah · Azm Hussain · Joseph Sturman · Yimeng Zhang · Felicity Baldwin · David Winter · Mike Hawkins · Raoul Reulen · Adnan Sharif

  Frontiers in Transplantation

  doi 10.3389/frtra.2026.1851859

• Case Report

  Published 16 June 2026

  Infliximab as ultima ratio in a case of refractory non-Crohn’s disease complex fistula system: case report and mini-review of the literature

  Nada Agbariah · Matthias Kis · Christine Manser · Luc Biedermann · Gerhard Rogler

  Frontiers in Gastroenterology

  doi 10.3389/fgstr.2026.1815049

• Review

  Published 4 June 2026

  Availability, accessibility, and economic feasibility of radionuclide therapies in Africa: a systematic review and quantitative infrastructure analysis

  Efrah Ahmed Ibrahim

  Frontiers in Nuclear Medicine

  doi 10.3389/fnume.2026.1825650

• Original Research

  Published 2 June 2026

  Comparative outcomes of focal HIFU versus active surveillance in low- and intermediate-risk localized prostate cancer: a 75-month retrospective cohort study

  Mohammad Jaabou · Maurizio Buscarini · Osama Zaytoun · Zachary Dovey · Brooke Hildebrand · Modassar Awan · Maida Bada · Mohammad Al Ogaili · Ahmad Rabie

  Frontiers in Urology

  doi 10.3389/fruro.2026.1801127

• Review

  Published 29 May 2026

  Next-generation imaging in prostate cancer

  Ahmed Rabie · Maurizio Buscarini · Osama Zaytoun

  Frontiers in Urology

  doi 10.3389/fruro.2026.1829407

• Systematic Review

  Published 20 May 2026

  Applications of large language models in tumor boards: a systematic review

  Benjamin Konzmann · Maurice Henkel · Christian Breit · Christian Wetterauer

  Oncology Reviews

  doi 10.3389/or.2026.1757059

• Review

  Published 12 May 2026

  Uncertain magnitude of benefit of early second-generation androgen receptor antagonist treatment in advanced prostate cancer

  Emma K. van de Weerdt · Ashley J. Duits · Michael J. Samson · John-John B. Schnog

  Oncology Reviews

  doi 10.3389/or.2026.1750202

• Brief Research Report

  Published 10 April 2026

  Liquid-based genomic profiling in high-risk localized prostate cancer

  Fabiana Bettoni · Elisângela Monteiro Coser · Ernande Xavier dos Santos · Amanda Rafaela Alves Canteli · Romualdo Morandi Filho · Vandeclécio Lira · Livia Loureiro · Marcia Dellamano · Raul Torrieri · Maria José Ferreira Alves · Leonardo Cardili · David Queiroz Borges Muniz · Éder Nisi Ilário · Roger Chammas · William Carlos Nahas · Diogo Assed Bastos · Anamaria Aranha Camargo

  Frontiers in Urology

  doi 10.3389/fruro.2026.1789586

• Original Research

  Published 30 March 2026

  Nanoemulsion formulation based delivery system enhances anticancer efficacy of pumpkin seed oil against prostate cancer

  Rupali Ghosh · Syed Abuzar Raza Rizvi · Nishat Afroz · Samar Husain Naqvi · Saima Wajid

  Frontiers in Nanotechnology

  doi 10.3389/fnano.2026.1805394

• Original Research

  Published 19 March 2026

  Transperineal versus transrectal systematic prostate biopsy in routine clinical practice: a real-world comparative study

  Anouar El Ghazzaly · Mohammed Mrabeti · Abdesamad El Bahri · Larbi Hamedoun · Mohammed Tetou · Mohammed Alami · Ahmed Ameur

  Frontiers in Urology

  doi 10.3389/fruro.2026.1806961

• Original Research

  Published 12 March 2026

  Radiobiological evaluation of the therapeutic effect of silver-111 for the ISOLPHARM project

  Alberto Arzenton · Aurora Leso · Francesca Rana · Giulia S. Valli · Elena Delgrosso · Laura Cansolino · Cinzia Ferrari · Silva Bortolussi · Isabella Guardamagna · Giorgio Baiocco · Giorgio Grosso · Davide Serafini · Andrea Gandini · Valerio Di Marco · Antonietta Donzella · Emilio Mariotti · Marcello Lunardon · Devid Maniglio · Germano Bonomi · Alberto Andrighetto

  Frontiers in Nuclear Medicine

  doi 10.3389/fnume.2026.1773638

• Case Report

  Published 10 March 2026

  Incidental detection of PDAC via 18 F-PSMA PET/CT in a patient with recurrent prostate cancer. A case report

  Giordano Savelli · Mattia Bonacina · Alberto Soffientini · Elvira Archiati · Claudio Bnà · Alberto Zaniboni

  Frontiers in Nuclear Medicine

  doi 10.3389/fnume.2026.1767321

• Original Research

  Published 12 January 2026

  Social determinants of health associated with the clinicopathological presentation of patients with prostate cancer in Kenya

  Charles Waihenya · S. M. Thumbi · Daniel Kinyuru Ojuka · Camille Ragin · Charnita Zeigler-Johnson

  Frontiers in Cancer Control and Society

  doi 10.3389/fcacs.2025.1649686

• Correction

  Published 12 December 2025

  Correction: Comparative dosimetric evaluation of 68Ga-PSMA and 18F-Choline PET/CT imaging in prostate cancer: implications for radiation safety and SUVmax correlation

  Hussein R. Kaafarani · Mohamad Haidar · Hanna El-Balaa

  Frontiers in Nuclear Medicine

  doi 10.3389/fnume.2025.1760153

• Original Research

  Published 1 December 2025

  Comparative dosimetric evaluation of 68Ga-PSMA and 18F-Choline PET/CT imaging in prostate cancer: implications for radiation safety and SUVmax correlation

  Hussein R. Kaafarani · Mohamad Haidar · Hanna El-Balaa

  Frontiers in Nuclear Medicine

  doi 10.3389/fnume.2025.1702390

• Nuclear Medicine

  Published 11 September 2025

  Platinum group metals for nuclear medicine, a luxurious dream or the future of imaging and therapy: a review

  Daniel G. Racz · Ivis F. Chaple

  Frontiers in Nuclear Medicine

  doi 10.3389/fnume.2025.1656374

• Original Research

  Published 2 September 2025

  Enhancing tumoricidal effects of radiation therapy with low-intensity focused ultrasound in murine breast cancers

  Michelle Marie Schumacher · Claudia Gutierrez Chavez · Beata Malachowska · Sanjay Pandey · Tatyana Tchaikovskaya · Saurabh Singh · Steve Barry · Rodney Macedo

  Frontiers in Acoustics

  doi 10.3389/facou.2025.1616297

  3,434 views

• Science archive

  Published 22 July 2025

  Severe lichenified skin rash associated with apalutamide administration

  Chisato Watanabe · Shujiro Hayashi · Shown Tokoro · Ken Igawa

  Journal of Cutaneous Immunology and Allergy

  doi 10.3389/jcia.2025.14936

• Cancer Control and Society

  Published 21 March 2025

  Barriers and facilitators to prostate cancer screening, early presentation and diagnosis-experiences of men diagnosed with prostate cancer in Kenya

  Charles Waihenya · S. M. Thumbi · Daniel Kinyuru Ojuka · Camille Ragin · Charnita Zeigler-Johnson

  Frontiers in Cancer Control and Society

  doi 10.3389/fcacs.2025.1521454

• Imaging

  Published 2 December 2024

  Video tracking of single cells to identify clustering behavior

  Mónica Suárez Korsnes · Håkon André Ramberg · Kristin Austlid Taskén · Reinert Korsnes

  Frontiers in Imaging

  doi 10.3389/fimag.2024.1443142

• Epigenetics and Epigenomics

  Published 19 July 2024

  Advancements in the clinical application of gene methylation for early cancer detection

  Xin Xu · Yanru Guo · Mulin Liu · Yunxiang Hu · Shijun Li

  Frontiers in Epigenetics and Epigenomics

  doi 10.3389/freae.2024.1430294